BIO 2020 Notebook: Fauci On Price Controls; Biotech's Financing Advantage; Progress Towards Universal Flu Vaccine

News and views from day two of BIO Digital include Jim Greenwood on the prospects for drug development legislation.

BIO 2020 Notebook
• Source: Shutterstock

The National Institute of Allergy and Infectious Diseases director Anthony Fauci’s talk with BIO CEO Michelle McMurray-Heath in a plenary devoted to COVID-19 vaccines turned to a discussion of “faith” after she raised the hot-button subject of price controls and asked if such measures would hurt his ability to partner with the private sector to bring vaccines to market.

"This is what's called a 'get Tony in trouble' question," Fauci replied with a smile. He said he had had...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip